
Bunion Correction Systems Market Report 2026
Global Outlook – By Type (Osteotomy, Arthrodesis, Lapidus, Exostectomy), By Surgery Type (Minimally Invasive, Traditional), By End-Use (Hospitals, Ambulatory Centers, Specialty Centers) – Market Size, Trends, Strategies, and Forecast to 2035
Bunion Correction Systems Market Overview
• Bunion Correction Systems market size has reached to $0.84 billion in 2025 • Expected to grow to $1.22 billion in 2030 at a compound annual growth rate (CAGR) of 7.7% • Growth Driver: The Increasing Prevalence Of Arthritis And Rheumatoid Arthritis Is Driving The Market Due To Rising Joint Deformities And Surgical Correction Demand • Market Trend: Minimally Invasive Bunion System Revolutionizes Surgical Correction And Recovery • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.What Is Covered Under Bunion Correction Systems Market?
Bunion correction systems are specialized medical devices and surgical tools designed to realign the metatarsophalangeal joint, stabilize bone structures, and correct the anatomical deformity caused by hallux valgus through minimally invasive or open procedures. These systems are used to alleviate pain, restore normal foot function, and prevent the progression of bunion-related complications following corrective surgical intervention. The main types of bunion correction systems are osteotomy, arthrodesis, lapidus, and exostectomy. Osteotomy is a surgical procedure that involves cutting and realigning the bones of the big toe (usually the first metatarsal) to correct deformities caused by bunions and restore proper joint alignment. The product types in these are correction systems, implants and accessories, and wearables, by surgery type minimally invasive and traditional, used in the end-use hospitals, ambulatory centers, and specialty centers.
What Is The Bunion Correction Systems Market Size and Share 2026?
The bunion correction systems market size has grown strongly in recent years. It will grow from $0.84 billion in 2025 to $0.91 billion in 2026 at a compound annual growth rate (CAGR) of 8.0%. The growth in the historic period can be attributed to reliance on traditional osteotomy and exostectomy techniques, limited availability of specialized correction systems, growing orthopedic surgical procedures, rising prevalence of hallux valgus, adoption of hospital-based surgical interventions.What Is The Bunion Correction Systems Market Growth Forecast?
The bunion correction systems market size is expected to see strong growth in the next few years. It will grow to $1.22 billion in 2030 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to development of advanced implants and wearable correction systems, expansion of ambulatory and specialty centers, increasing minimally invasive procedures, integration of digital imaging and surgical planning tools, rising patient awareness and demand for faster recovery. Major trends in the forecast period include increasing adoption of minimally invasive bunion correction procedures, rising demand for advanced implants and accessories, expansion of specialty foot care centers, focus on post-surgical recovery and rehabilitation solutions, growing awareness of foot health and orthopedic care.Global Bunion Correction Systems Market Segmentation
1) By Type: Osteotomy, Arthrodesis, Lapidus, Exostectomy 2) By Surgery Type: Minimally Invasive, Traditional 3) By End-Use: Hospitals, Ambulatory Centers, Specialty Centers Subsegments: 1) By Osteotomy: Chevron Osteotomy, Scarf Osteotomy, Akin Osteotomy 2) By Arthrodesis: First Metatarsophalangeal (MTP) Joint Arthrodesis, Midfoot Arthrodesis, Tarsometatarsal Arthrodesis 3) By Lapidus: Lapidus Procedure With Plate Fixation, Lapidus Procedure With Screw Fixation, Modified Lapidus Procedure 4) By Exostectomy: Simple Exostectomy, Exostectomy With Soft Tissue Release, Exostectomy With BunionectomyWhat Is The Driver Of The Bunion Correction Systems Market?
The increasing prevalence of arthritis and rheumatoid arthritis is expected to propel the growth of the bunion correction systems market going forward. Arthritis is a broad term describing inflammation and degeneration of one or more joints, with rheumatoid arthritis (RA) being a chronic autoimmune disorder characterized by persistent joint inflammation and progressive tissue damage. The increasing prevalence of arthritis and RA is driven by factors such as aging populations, which contribute to higher incidences of joint wear and autoimmune responses over time. Bunion correction systems provide effective surgical solutions to correct deformities and alleviate joint stress, thereby improving mobility and quality of life for patients affected by arthritis-related foot conditions. For instance, in February 2024, according to Arthritis Australia, an Australia-based not-for-profit organization focused on arthritis awareness, advocacy, and support, Approximately 15% of Australians across all age groups are living with arthritis, making it one of the nation’s most prevalent chronic health conditions. Projections indicate that the arthritis patient population is expected to rise to 5.39 million by 2040, reflecting 31% growth and representing an additional 1.28 million affected individuals. By 2040, the number of people living with rheumatoid arthritis is projected to reach 280,040 males and 479,828 females. Therefore, the increasing prevalence of arthritis and rheumatoid arthritis is driving the bunion correction systems industry.Key Players In The Global Bunion Correction Systems Market
Major companies operating in the bunion correction systems market are Johnson and Johnson MedTech, Stryker Corporation, Zimmer Biomet Holdings Inc, Arthrex Inc, Enovis Corporation, Wright Medical Technology Inc, Orthofix Holdings Inc, Paragon 28, Acumed LLC, Treace Medical Concepts Inc, Medartis AG, Nextremity Solutions Inc, BioPro Inc, Extremity Medical LLC, Integra LifeSciences Holdings Corporation, Smith and Nephew plc, DePuy Synthes Inc, MicroPort Orthopedics Inc, Aesculap AG, Vilex LLCGlobal Bunion Correction Systems Market Trends and Insights
Major companies operating in the bunion correction systems market are focusing on developing innovative advancements such as the minimally invasive bunion correction system to provide surgeons with an advanced surgical solution that improves bunion correction outcomes through minimally invasive techniques. A minimally invasive bunion correction system is a surgical technique and set of specialized tools designed to realign the big toe joint and correct bunion deformities through small incisions, reducing tissue damage, recovery time, and postoperative complications. For instance, in February 2024, Paragon 28 Inc., a US-based medical device company specializing in foot and ankle orthopedics, launched the PRECISION MIS Bunion System, a next-generation solution for minimally invasive surgical correction of bunions. This system is engineered to support distal metatarsal osteotomy through a guided, joint-preserving technique that enhances surgical precision while minimizing tissue disruption. This is designed for tri-planar correction that incorporates an outrigger-based mechanism and specialized cannulated screws to optimize bone alignment and stability, thereby promoting faster healing and reducing postoperative discomfort.What Are Latest Mergers And Acquisitions In The Bunion Correction Systems Market?
In June 2023, Enovis Corporation, a U.S.-based medical technology company specializing in reconstructive and extremity solutions, surgical instruments, and orthopedic implants, acquired Novastep SAS for US$ 96.9 million. Through this acquisition, Enovis Corporation aims to expand its portfolio of bunion correction systems and strengthen its minimally invasive foot and ankle product offerings, thereby enhancing its overall range and customer reach in the rapidly growing foot and ankle surgical market. Novastep SAS is a France-based developer of minimally invasive foot and ankle surgical solutions, including the Pecaplasty MIS bunion system.Regional Outlook
North America was the largest region in the bunion correction systems market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, SpainWhat Defines the Bunion Correction Systems Market?
The bunion correction systems market consists of sales of bone plates, bone screws, fixation devices, surgical guides, 3D-printed patient-specific instruments, cannulated compression screws, staple fixation systems, and orthopedic power tools. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.Bunion Correction Systems Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $0.91 billion |
| Revenue Forecast In 2035 | $1.22 billion |
| Growth Rate | CAGR of 8.0% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Type, Surgery Type, End-Use |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | Johnson and Johnson MedTech, Stryker Corporation, Zimmer Biomet Holdings Inc, Arthrex Inc, Enovis Corporation, Wright Medical Technology Inc, Orthofix Holdings Inc, Paragon 28, Acumed LLC, Treace Medical Concepts Inc, Medartis AG, Nextremity Solutions Inc, BioPro Inc, Extremity Medical LLC, Integra LifeSciences Holdings Corporation, Smith and Nephew plc, DePuy Synthes Inc, MicroPort Orthopedics Inc, Aesculap AG, Vilex LLC |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
